Ligand Pharmaceuticals stock tanks after extremely critical Citron report
January 16, 2019 at 16:09 PM EST
Shares of Ligand Pharmaceuticals Inc. fell 17% on Wednesday after Citron Research, headed by famed short seller Andrew Left, called the drug company’s pipeline a ‘pipe dream.’